.jpg)
PlaBiTe Growth
PlaBiTe is a biotechnology company that develops platelet-derived bioproducts for biomedical research and regenerative medicine. Research carried out by the Platelet Research Group at the Asturias Institute of Health Research (ISPA) enabled the characterization of the regenerative potential of platelets and their ability to modulate biological processes through the factors stored in their granules. Building on this knowledge, a patented technology was developed that enables the production of defined, reproducible, plasma-free secretomes, overcoming the high variability and autologous dependency of existing methods.
This platform makes it possible to manufacture standardized, safe, and scalable bioproducts, offering a sustainable and controlled alternative for biotechnological and clinical applications. Its unique methodology paves the way for the development of a universal biological drug based on growth factors, with an initial application in chronic wounds, positioning PlaBiTe at the forefront of advanced regenerative therapies.
Among the biotechnological applications enabled by this platform, PlaBiTe Growth® stands out as the first product that PlaBiTe will launch to the market in 2026. PlaBiTe Growth® is a 100% human-derived cell culture supplement based on platelet secretomes highly enriched in growth factors.
Initially, it will be available as an R.U.O. (Research Use Only) product for cell culture research, and later it will evolve into a clinical-grade bioproduct for cell therapy applications. Its formulation provides robust stimulation of cell proliferation and survival, offering a superior alternative to conventional sera.
Unlike other human-derived supplements, PlaBiTe Growth® is fibrinogen-free, eliminating the need to add anticoagulants such as porcine-derived heparin or to perform defibrination steps that can alter biological activity. Its production process is highly standardized, ensuring quality, stability, and batch-to-batch consistency — all essential features for advanced research and bioprocessing.
